Fecal Volatile Metabolomics Predict Gram-Negative Late-Onset Sepsis in Preterm Infants: A Nationwide Case-Control Study
- PMID: 36985146
- PMCID: PMC10054547
- DOI: 10.3390/microorganisms11030572
Fecal Volatile Metabolomics Predict Gram-Negative Late-Onset Sepsis in Preterm Infants: A Nationwide Case-Control Study
Abstract
Early detection of late-onset sepsis (LOS) in preterm infants is crucial since timely treatment initiation is a key prognostic factor. We hypothesized that fecal volatile organic compounds (VOCs), reflecting microbiota composition and function, could serve as a non-invasive biomarker for preclinical pathogen-specific LOS detection. Fecal samples and clinical data of all preterm infants (≤30 weeks' gestation) admitted at nine neonatal intensive care units in the Netherlands and Belgium were collected daily. Samples from one to three days before LOS onset were analyzed by gas chromatography-ion mobility spectrometry (GC-IMS), a technique based on pattern recognition, and gas chromatography-time of flight-mass spectrometry (GC-TOF-MS), to identify unique metabolites. Fecal VOC profiles and metabolites from infants with LOS were compared with matched controls. Samples from 121 LOS infants and 121 matched controls were analyzed using GC-IMS, and from 34 LOS infants and 34 matched controls using GC-TOF-MS. Differences in fecal VOCs were most profound one and two days preceding Escherichia coli LOS (Area Under Curve; p-value: 0.73; p = 0.02, 0.83; p < 0.002, respectively) and two and three days before gram-negative LOS (0.81; p < 0.001, 0.85; p < 0.001, respectively). GC-TOF-MS identified pathogen-specific discriminative metabolites for LOS. This study underlines the potential for VOCs as a non-invasive preclinical diagnostic LOS biomarker.
Keywords: fecal biomarker; gas chromatography—ion mobility spectrometry; gas chromatography—time of flight—mass spectrometry; microbiota; neonatology; volatile organic compounds.
Conflict of interest statement
None of the co-authors received a honorarium, grant, or other form of payment for the production of this manuscript. Outside the submitted work, N.K.H.d.B. has served as a speaker for AbbVie and MSD. He has also served as a consultant and/or principal investigator for TEVA Pharma BV and Takeda. He has received a (unrestricted) research grant from Dr Falk, TEVA Pharma BV, MLDS and Takeda. The other authors have nothing to declare.
Figures


Similar articles
-
Late-onset Sepsis in Preterm Infants Can Be Detected Preclinically by Fecal Volatile Organic Compound Analysis: A Prospective, Multicenter Cohort Study.Clin Infect Dis. 2019 Jan 1;68(1):70-77. doi: 10.1093/cid/ciy383. Clin Infect Dis. 2019. PMID: 29931245
-
Fecal Microbiota and Volatile Metabolome Pattern Alterations Precede Late-Onset Meningitis in Preterm Neonates.J Infect Dis. 2025 Jul 11;231(6):1382-1391. doi: 10.1093/infdis/jiae265. J Infect Dis. 2025. PMID: 38781449 Free PMC article.
-
Preclinical Detection of Non-catheter Related Late-onset Sepsis in Preterm Infants by Fecal Volatile Compounds Analysis: A Prospective, Multi-center Cohort Study.Pediatr Infect Dis J. 2020 Apr;39(4):330-335. doi: 10.1097/INF.0000000000002589. Pediatr Infect Dis J. 2020. PMID: 32032172
-
The Potential of Fecal Volatile Organic Compound Analysis for the Early Diagnosis of Late-Onset Sepsis in Preterm Infants: A Narrative Review.Sensors (Basel). 2024 May 16;24(10):3162. doi: 10.3390/s24103162. Sensors (Basel). 2024. PMID: 38794014 Free PMC article. Review.
-
The potential of gut microbiota and fecal volatile organic compounds analysis as early diagnostic biomarker for necrotizing enterocolitis and sepsis in preterm infants.Expert Rev Gastroenterol Hepatol. 2018 May;12(5):457-470. doi: 10.1080/17474124.2018.1446826. Epub 2018 Mar 6. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29488419 Review.
Cited by
-
Multi-omics decodes host-specific and environmental microbiome interactions in sepsis.Front Microbiol. 2025 Jun 26;16:1618177. doi: 10.3389/fmicb.2025.1618177. eCollection 2025. Front Microbiol. 2025. PMID: 40641871 Free PMC article. Review.
-
Biomarkers of Neonatal Sepsis: Where We Are and Where We Are Going.Antibiotics (Basel). 2023 Jul 26;12(8):1233. doi: 10.3390/antibiotics12081233. Antibiotics (Basel). 2023. PMID: 37627653 Free PMC article. Review.
-
Volatile Organic Compound Assessment as a Screening Tool for Early Detection of Gastrointestinal Diseases.Microorganisms. 2023 Jul 17;11(7):1822. doi: 10.3390/microorganisms11071822. Microorganisms. 2023. PMID: 37512994 Free PMC article. Review.
-
Survival of the Littlest: Navigating Sepsis Diagnosis beyond Inflammation in Preterm Neonates.J Proteome Res. 2025 Jun 6;24(6):2846-2860. doi: 10.1021/acs.jproteome.4c01072. Epub 2025 Apr 30. J Proteome Res. 2025. PMID: 40305123 Free PMC article.
-
Identification of serum metabolite biomarkers in premature infants with bronchopulmonary dysplasia: protocol for a multicentre prospective observational cohort study.BMJ Open. 2025 Jan 15;15(1):e089064. doi: 10.1136/bmjopen-2024-089064. BMJ Open. 2025. PMID: 39819932 Free PMC article.
References
-
- Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., Lemons J.A., Donovan E.F., Stark A.R., Tyson J.E., et al. Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–291. doi: 10.1542/peds.110.2.285. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous